W 060/07 OSR — Hikma Pharmaceuticals Plc
|To||Hikma Pharmaceuticals Plc|
5 Appold Street
London, EC2A 2HA
|DFSA Firm Reference No.||F000276|
THE DFSA HEREBY GIVES NOTICE THAT:
The Rules specified in the table herein do not apply to the above mentioned Person in the form appearing in the Rulebook but instead apply to that Person in the modified form prescribed in the table below.
This notice is issued by the DFSA under Article 25 of the Regulatory Law 2004.
Effective date: This notice comes into effect on 29 July 2007 and remain in force until 8 September 2007 or until further notice, which ever is the earlier.
The Rules listed in the left hand column of the table below are modified as shown in the right hand column of the table. In this table, underlining indicates new text and striking through indicates deleted text.
The version of Rules to which this notice relates is OSR/VER8/06-07.
Under OSR A2.1.1
The modifications in respect of the Rules specified above remain in effect for the duration of the period set out above on condition that:
"It is unable to meet the DFSA's requirement to publish its semi-annual financial statement within 60 days of the end of the period to which the statement relates. It has sought and obtained from the DFSA relief from this requirement. The effect of this relief is to extend the latest date for publication for an audited semi-annual financial statement to 7 September 2007."
The provisions in this notice are to be construed in accordance with GEN section 6.2 as if these provisions are provisions of the Rulebook.
Defined terms are identified in this notice by the capitalisation of the initial letter of a word or of each word in a phrase and are defined in the Glossary (GLO). Unless the context otherwise requires, where capitalisation of the initial letter is not used, an expression has its natural meaning.
This notice was issued by:
|Name :||David W. Knott|
|Position :||Chief Executive|
|Date :||29 July 2007|